Hepatotropic Properties of SARS-CoV-2—Preliminary Results of Cross-Sectional Observational Study from the First Wave COVID-19 Pandemic
Liver injury—expressed as elevated liver enzymes—is common in patients with COVID-19. Little is known about the potential mechanisms of liver damage by SARS-CoV-2. A direct cytopathic effect on hepatocytes as well as injury related to hypoxia or hepatotoxicity are being considered. The aim of the st...
Main Authors: | Hanna Wiśniewska, Karolina Skonieczna-Żydecka, Miłosz Parczewski, Jolanta Niścigorska-Olsen, Ewa Karpińska, Monika Hornung, Krzysztof Jurczyk, Magdalena Witak-Jędra, Łukasz Laurans, Katarzyna Maciejewska, Łukasz Socha, Agnieszka Leonciuk, Dorota Bander, Malwina Karasińska-Cieślak, Bogusz Aksak-Wąs, Marta Wawrzynowicz-Syczewska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/4/672 |
Similar Items
-
PHARMACOEPIDEMIOLOGICAL EVALUATION OF HEPATOTROPIC THERAPY IN REAL CLINICAL PRACTICE
by: D. V. Blinov, et al.
Published: (2015-06-01) -
Bioengineered Liver Cell Models of Hepatotropic Infections
by: Francisca Arez, et al.
Published: (2021-04-01) -
A non-hepatotropic parasite infection increases mortality in the acetaminophen-induced acute liver failure murine model: possible roles for IL-5 and IL-6
by: Marco A De León-Nava, et al. -
Human immunodeficiency virus and the liver: The impact of coinfection with hepatotropic viruses
by: Leonor Huerta, et al.
Published: (2019-03-01) -
Progress and Challenges in the Use of a Liver-on-a-Chip for Hepatotropic Infectious Diseases
by: Kasem Kulkeaw, et al.
Published: (2021-07-01)